| Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Careers Employment > Career Change - Making the Big Leap |
|
Other Articles - Career Change - Making the Big Leap
Often people contemplate a change of career with some trepidation, holding fears such as: - Will I be able to achieve what I am aiming for? - What if I don’t earn enough money? - Will I regret my decision? According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product One common tool for helping you to decide whether you are right in wanting to change jobs is for you to draw up a list of costs and benefits of making the decision to make a big leap into a new ca ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in reer. Whilst this approach is useful, it is unlikely to resolve the fears or anxieties you have about making the big leap. In order to help with those, I would suggest the following approach: 1. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. Make a Risk Assessment of the most significant risks of deciding to change career. In your Risk Assessment, for each potential risk you think of, set out: – What will be the potential negative consequ here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe nces if the risk materialises – How likely you think it is that the risk will materialise (You can either use a scoring scale or else define things in a range of probabilities – e.g. ‘Very likely’, ‘ d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro Quite likely’, ‘Possible’ etc.) – Then give each risk a Priority Rating (e.g. 10 means you need to treat the risk with the highest priority, 0 means it is of no significance at all). Note that in order t ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc o assign priority you will need to balance the two factors listed above (potential consequences and likelihood). For example, if a risk is very likely to materialise but the potential negative consequences from easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi it are very small, then that risk probably does not need a particularly high priority. because it will not jeopardise your success even if it materialises 2. Once you have assigned your priorities you need to < nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically >create a Risk Management Plan, to deal with all the risks but in particular for those risks which you have judged to be of highest priority. In the plan for each risk set out: - What you can do now to and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ reduce the likelihood of the risk materialising at all (e.g. through advance planning and research of the option you are pursuing and how to achieve it). - What can you do to limit the impact if the risk ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi does materialise (this might for example include having a contingency plan in place for what you will do if the new career does not work out as expected). You can use your Risk Assessment and Risk Manageme ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nt Plans to help you decide for each risk whether it is a risk that you are prepared to take and use your Risk Management Plan to help you plan and implement step by step actions to help you maintain prog dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ess if you do decide to pursue your dream. If you find it difficult to be objective about what the risks are or about how to manage them, then you may benefit from the support of a coach to help you work throug cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin h the options and decide what you want to do. The other element where a good coach may be able to help you is in dealing with your mental inhibitions about taking action – for example by showing you p tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ractical techniques to assist you when your motivation is low or when negative thoughts are running through your mind. It is important to include mental or emotional aspects amongst the risks that you asses t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s, if these are significant for you. For example, one of my clients who decided to create her own business in a creative field identified as one of the main risks: Risk of feeling lonely and isolated and los ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust of confidence. Through discussion in coaching we were able to create simple elements in the Risk Management Plan to help her plan for how to deal with this risk if it arose, including: - identif y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ying and making use of possible support systems she might use - deciding not to be over critical of herself if she did start to lose confidence, but to learn from situations - reminding herself o . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de f the benefits of achieving her career change when difficulties arose - following the Project Plan she had created in coaching sessions to facilitate her career change in a step by step manner and up elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip dating it at regular intervals. Through the assistance of the Risk Management Plan she was able to make the transition from a stressful, unfulfilling career into a career which she found creative and meaningful tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Should You Start a Cleaning Business With Your Spouse? Successful Brand Name Advertising In The Philippines 10 Strategies For Managing Workplace Culture
|